The Lymphatic-Bone Axis in Cancer Metastasis

Area of Science:

• Oncology
• Cancer Metastasis
• Lymphatic Biology

Background:

• Bone metastasis is a major cause of cancer mortality.
• Current models of skeletal dissemination via hematogenous spread do not fully explain clinical observations.
• Lymph node metastasis is a strong predictor of bone involvement, suggesting a more active role for lymph nodes.

Purpose of the Study:

• To introduce the Lymphatic-Bone Axis framework.
• To synthesize evidence on how lymph nodes prime tumor cells for bone metastasis.
• To propose future research directions and discuss translational implications.

Main Methods:

• Review of existing literature and emerging evidence.
• Synthesis of data on tumor cell priming within the lymph node microenvironment.
• Discussion of preclinical data on intranodal intravasation.

Main Results:

• Lymph nodes act as 'evolutionary gateways' that sculpt bone-tropic metastatic clones.
• The lymph node microenvironment primes tumor cells via CCR7-CXCR4 switching, osteomimicry, and metabolic reprogramming.
• High endothelial venules (HEVs) provide a direct route for tumor cell entry into circulation.

Conclusions:

• The Lymphatic-Bone Axis framework integrates lymphatic biology into bone metastasis.
• Understanding lymphatic priming is crucial for developing effective therapies.
• Multimodal approaches targeting both lymphatic transit and the bone microenvironment are needed.